Schedule 13D ownership disclosure
Actinium Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 00507W107
Event date: 2016-04-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-16-004206
- Form type
- SC 13D
- Filer
- Actinium Pharmaceuticals, Inc.
- CIK
- CIK 1388320
- Filed
- Apr 21, 2016
- Reporting period
- Apr 19, 2016
- Description
- Schedule 13D beneficial ownership